abstract |
The present invention relates to a pharmaceutical composition comprising? -OH-vitamin D 2 : 1?, 24 (S) - (OH) 2 -vitamin D 2 ; 1? -OH-vitamin D 4 ; Or a method of preventing the loss of bone mass or bone mineral content of a person suffering from secondary hyperparathyroidism by administering a sufficient amount of 1?, 24 (R) - (OH) 2 - vitamin D 4 . |